A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients
International Journal of Radiation Oncology*Biology*Physics(2023)
摘要
Mucosal sparing radiation is well tolerated in select resected human papillomavirus-related oropharyngeal squamous cell carcinoma with a low risk of recurrence at the mucosal primary site, a low rate of percutaneous endoscopic gastrostomy tube placement, and few radiation-related grade ≥3 adverse events.
更多查看译文
关键词
mucosal sparing radiation therapy,resected oropharyngeal cancer patients,radiation therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要